450 related articles for article (PubMed ID: 23065788)
21. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
22. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
23. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
[TBL] [Abstract][Full Text] [Related]
24. Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach.
Tecchio F; Zito G; Zappasodi F; Dell' Acqua ML; Landi D; Nardo D; Lupoi D; Rossini PM; Filippi MM
Brain; 2008 Jul; 131(Pt 7):1783-92. PubMed ID: 18502782
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of cortical lesions in MS: relation with cognitive impairment.
Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
[TBL] [Abstract][Full Text] [Related]
26. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
[TBL] [Abstract][Full Text] [Related]
27. Cortical atrophy is relevant in multiple sclerosis at clinical onset.
Calabrese M; Atzori M; Bernardi V; Morra A; Romualdi C; Rinaldi L; McAuliffe MJ; Barachino L; Perini P; Fischl B; Battistin L; Gallo P
J Neurol; 2007 Sep; 254(9):1212-20. PubMed ID: 17361339
[TBL] [Abstract][Full Text] [Related]
28. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
Río J; Rovira A; Tintoré M; Huerga E; Nos C; Tellez N; Tur C; Comabella M; Montalban X
Mult Scler; 2008 May; 14(4):479-84. PubMed ID: 18562504
[TBL] [Abstract][Full Text] [Related]
29. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
30. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
31. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
Strasser-Fuchs S; Enzinger C; Ropele S; Wallner M; Fazekas F
Mult Scler; 2008 Mar; 14(2):205-11. PubMed ID: 17986507
[TBL] [Abstract][Full Text] [Related]
32. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].
Pascual-Lozano AM; Martínez-Bisbal MC; Boscá-Blasco I; Valero-Merino C; Coret-Ferrer F; Martí-Bonmatí L; Martínez-Granados B; Celda B; Casanova-Estruch B
Rev Neurol; 2007 Oct 16-31; 45(8):468-73. PubMed ID: 17948212
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.
Treaba CA; Granberg TE; Sormani MP; Herranz E; Ouellette RA; Louapre C; Sloane JA; Kinkel RP; Mainero C
Radiology; 2019 Jun; 291(3):740-749. PubMed ID: 30964421
[TBL] [Abstract][Full Text] [Related]
34. Cortical pathology in multiple sclerosis.
Stadelmann C; Albert M; Wegner C; Brück W
Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
[TBL] [Abstract][Full Text] [Related]
35. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
Fisniku LK; Altmann DR; Cercignani M; Tozer DJ; Chard DT; Jackson JS; Miszkiel KA; Schmierer K; Thompson AJ; Miller DH
Mult Scler; 2009 Jun; 15(6):668-77. PubMed ID: 19435751
[TBL] [Abstract][Full Text] [Related]
36. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
Chard DT; Griffin CM; Parker GJ; Kapoor R; Thompson AJ; Miller DH
Brain; 2002 Feb; 125(Pt 2):327-37. PubMed ID: 11844733
[TBL] [Abstract][Full Text] [Related]
37. Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
Harrison DM; Roy S; Oh J; Izbudak I; Pham D; Courtney S; Caffo B; Jones CK; van Zijl P; Calabresi PA
JAMA Neurol; 2015 Sep; 72(9):1004-12. PubMed ID: 26192316
[TBL] [Abstract][Full Text] [Related]
38. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
39. Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis.
Beck ES; Mullins WA; Dos Santos Silva J; Filippini S; Parvathaneni P; Maranzano J; Morrison M; Suto DJ; Donnay C; Dieckhaus H; Luciano NJ; Sharma K; Gaitán MI; Liu J; de Zwart JA; van Gelderen P; Cortese I; Narayanan S; Duyn JH; Nair G; Sati P; Reich DS
Brain Commun; 2024; 6(3):fcae158. PubMed ID: 38818331
[TBL] [Abstract][Full Text] [Related]
40. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; Montanari E; Cifelli A; Federico A; Smith SM
Neurology; 2003 Apr; 60(7):1157-62. PubMed ID: 12682324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
